UA26939C2 - Засіб для лікуваhhя аутоімуhhих захворюваhь і спосіб їх лікуваhhя - Google Patents

Засіб для лікуваhhя аутоімуhhих захворюваhь і спосіб їх лікуваhhя

Info

Publication number
UA26939C2
UA26939C2 UA96093436A UA96093436A UA26939C2 UA 26939 C2 UA26939 C2 UA 26939C2 UA 96093436 A UA96093436 A UA 96093436A UA 96093436 A UA96093436 A UA 96093436A UA 26939 C2 UA26939 C2 UA 26939C2
Authority
UA
Ukraine
Prior art keywords
autoimmune diseases
treating autoimmune
agent
treating
diseases
Prior art date
Application number
UA96093436A
Other languages
English (en)
Russian (ru)
Inventor
Іван Ніколаєвіч Головістіков
Иван Николаевич Головистиков
Юрій Сємьоhовіч Татариhов
Халлар Абдумуслімовіч Аліханов
Халлар Абдумуслимович Алиханов
Лєонід Язоновіч Качарава
Леонид Язонович Качарава
Original Assignee
Іван Ніколаєвіч Головістіков
Иван Николаевич Головистиков
Лєонід Язоновіч Качарава
Леонид Язонович Качарава
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Іван Ніколаєвіч Головістіков, Иван Николаевич Головистиков, Лєонід Язоновіч Качарава, Леонид Язонович Качарава filed Critical Іван Ніколаєвіч Головістіков
Publication of UA26939C2 publication Critical patent/UA26939C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Винахід належить до галузі медицини. Трофобластичний бета-1-глікопротеїн застосовується як засіб для лікування аутоімунних захворювань з імунодефіцитом супресорів.
UA96093436A 1994-03-18 1995-03-16 Засіб для лікуваhhя аутоімуhhих захворюваhь і спосіб їх лікуваhhя UA26939C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU9494008169A RU2056852C1 (ru) 1994-03-18 1994-03-18 Средство для лечения аутоиммунных заболеваний с иммунодефицитом супрессоров и способ лечения аутоиммунных заболеваний
PCT/RU1995/000047 WO1995025531A1 (en) 1994-03-18 1995-03-16 Means for treating auto-immune diseases and method of treatment

Publications (1)

Publication Number Publication Date
UA26939C2 true UA26939C2 (uk) 1999-12-29

Family

ID=20153349

Family Applications (1)

Application Number Title Priority Date Filing Date
UA96093436A UA26939C2 (uk) 1994-03-18 1995-03-16 Засіб для лікуваhhя аутоімуhhих захворюваhь і спосіб їх лікуваhhя

Country Status (22)

Country Link
US (1) US6150326A (uk)
EP (1) EP0790059B1 (uk)
JP (1) JPH09510473A (uk)
KR (1) KR100382252B1 (uk)
CN (1) CN1146156A (uk)
AT (1) ATE260111T1 (uk)
AU (1) AU699896B2 (uk)
BG (1) BG62759B1 (uk)
CA (1) CA2185892A1 (uk)
CZ (1) CZ285856B6 (uk)
DE (2) DE790059T1 (uk)
ES (1) ES2107980T1 (uk)
FI (1) FI963671A7 (uk)
GE (1) GEP20012377B (uk)
GR (1) GR980300023T1 (uk)
HU (1) HUT75720A (uk)
NO (1) NO963911L (uk)
PL (1) PL179765B1 (uk)
RU (1) RU2056852C1 (uk)
SK (1) SK281948B6 (uk)
UA (1) UA26939C2 (uk)
WO (1) WO1995025531A1 (uk)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2120298C1 (ru) * 1995-11-28 1998-10-20 Товарищество с ограниченной ответственностью "Верта" Иммуностимулятор и препарат на его основе
FR2747041B1 (fr) * 1996-04-05 1998-05-22 Cird Galderma Utilisation de derives benzonaphtaleniques pour la fabrication de medicaments destines au traitement des neuropathies
GB0030729D0 (en) * 2000-12-16 2001-01-31 Univ Nottingham Substituted-4-Quinolones
CA2501940A1 (en) * 2002-10-09 2004-04-22 Tolerrx, Inc. Molecules preferentially associated with effector t cells or regulatory t cells and methods of their use
RU2303995C1 (ru) * 2006-04-28 2007-08-10 Халлар Абдумуслимович Алиханов Средство, обладающее иммунорегуляторным свойством и его применение для лечения аутоиммунных заболеваний

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1107772B (it) * 1977-08-22 1985-11-25 Cancer Res Inst Royal Procedimento per la produzione di complessi macromolecolari prodotto ottenuto e composizioni farmaceutiche che lo contengono come ingrediente attivo
JPS61186322A (ja) * 1985-02-13 1986-08-20 Nippon Univ 免疾調節剤
IT1188646B (it) * 1986-04-09 1988-01-20 Ellem Ind Farmaceutica Tripeptide ad attivita' immunostimolante
US4803072A (en) * 1986-09-10 1989-02-07 Smithkline Beckman Corporation Immunomodulation
FR2609632B1 (fr) * 1987-01-21 1991-03-29 Shelly Marc Nouvelle application therapeutique de la 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinon-6-one et les compositions pharmaceutiques destinees a cet usage
US5169835A (en) * 1989-01-18 1992-12-08 Oklahoma Medical Research Foundation Pregancy specific proteins applications
FR2650183A1 (fr) * 1989-07-25 1991-02-01 Pasteur Institut Proteines immunostimulantes, anticorps monoclonaux et polyclonaux correspondants, hybridomes correspondants et application de ces produits a des fins therapeutiques et de diagnostic
US5118669A (en) * 1989-09-20 1992-06-02 Hitachi Chemical Co., Ltd. Peptides and intermediates therefor useful as antiallergic agents, vasodilators and immunoregulators
US5559097A (en) * 1990-01-12 1996-09-24 Idaho Research Foundation, Inc. Use of a pregnancy specific protein as an immunosuppressive
RU1836957C (ru) * 1990-03-25 1993-08-30 2-й Московский государственный медицинский институт им.Н.И.Пирогова Способ получени трофобластического бета @ -гликопротеина
GB2251186A (en) * 1990-12-04 1992-07-01 Randall Neal Gatz Polypeptide for use in treatment of autoimmune disease

Also Published As

Publication number Publication date
JPH09510473A (ja) 1997-10-21
US6150326A (en) 2000-11-21
NO963911D0 (no) 1996-09-18
HU9602558D0 (en) 1996-11-28
BG100921A (bg) 1997-12-30
HUT75720A (en) 1997-05-28
CZ285856B6 (cs) 1999-11-17
GEP20012377B (en) 2001-03-25
KR970701557A (ko) 1997-04-12
FI963671A0 (fi) 1996-09-17
BG62759B1 (bg) 2000-07-31
RU2056852C1 (ru) 1996-03-27
WO1995025531A1 (en) 1995-09-28
FI963671L (fi) 1996-11-14
AU699896B2 (en) 1998-12-17
CA2185892A1 (en) 1995-09-28
NO963911L (no) 1996-11-08
CZ274796A3 (en) 1997-06-11
DE790059T1 (de) 1998-03-12
AU2087495A (en) 1995-10-09
KR100382252B1 (ko) 2003-07-07
SK281948B6 (sk) 2001-09-11
EP0790059A4 (en) 2000-11-02
EP0790059B1 (en) 2004-02-25
PL316311A1 (en) 1997-01-06
PL179765B1 (pl) 2000-10-31
SK118796A3 (en) 1997-06-04
GR980300023T1 (en) 1998-04-30
EP0790059A1 (en) 1997-08-20
FI963671A7 (fi) 1996-11-14
DE69532611D1 (de) 2004-04-01
ATE260111T1 (de) 2004-03-15
CN1146156A (zh) 1997-03-26
ES2107980T1 (es) 1997-12-16

Similar Documents

Publication Publication Date Title
UA32429C2 (uk) Засіб для лікування нетримання сечі
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
IL114003A0 (en) Bicyclic compounds
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
DK0880350T3 (da) Behandling af dissemineret sklerose
IL115733A (en) Binding agents to cd23 and their use in the manufacture of a medicament
FI943625A7 (fi) Menetelmiä tulehduksellisten ihotautien hoitamiseksi
IL119462A (en) 1-trimethylphenyl-3-substituted 1H-pyrrol-2-amines
GB9406857D0 (en) Improvements in or relating to organic compounds
DE69327850D1 (de) Ungesättigte carboran-silan oder carboran-siloxanpolymerisate
PL310474A1 (en) Application of rilusole in treating neuro-aids diseases
ATE129228T1 (de) Neue 15,16-seco-19-nor-progestine.
BG101040A (en) Benzopyrans and their use as therapeutic agents
UA26939C2 (uk) Засіб для лікуваhhя аутоімуhhих захворюваhь і спосіб їх лікуваhhя
EA199800866A1 (ru) Способ снятия боли
ZA923935B (en) New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments
ATE211920T1 (de) Verwendung von relaxin als schmerzstiller und - dämpfer für starken schmerz
GR3021171T3 (en) Use of hyaluronic acid and forms to prevent arterial restenosis.
PL328949A1 (en) Method of treatng excessive aggression
IL106064A0 (en) Gallium complexes for the treatment of free radicalinduced diseases
ATE222498T1 (de) Putamen ovi
EA199800818A1 (ru) Способ лечения бессонницы
UA18225A (uk) Спосіб лікуваhhя раh
MX9700626A (es) USO DE AZASPIRANOS EN LA REPARACIaN DE COMPOSICIONES PARA TRATAR INFECCIONES OPORTUNISTAS.
MX9407703A (es) METODO PARA EL TRATAMIENTO DEL CHOQUE PUTREFACTIVO UTILIZANDO TIMOSINAa1.